Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have been assigned a consensus rating of “Hold” from the six analysts that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokers that have issued a report on the stock in the last year is $18.00.
AFYA has been the subject of a number of research reports. Bank of America restated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. JPMorgan Chase & Co. reduced their price target on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Finally, Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th.
Check Out Our Latest Analysis on AFYA
Afya Trading Up 1.2%
Insider Buying and Selling
In related news, VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the sale, the vice president owned 34,530 shares of the company’s stock, valued at $511,044. This trade represents a 22.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Lelio De Souza Junior sold 36,204 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total transaction of $543,060.00. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 87,745 shares of company stock valued at $1,314,175. 0.80% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Afya
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Swedbank AB boosted its holdings in Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after acquiring an additional 119,200 shares during the last quarter. Fairtree Asset Management Pty Ltd increased its position in Afya by 22.3% in the fourth quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after purchasing an additional 5,599 shares during the period. Banco BTG Pactual S.A. bought a new stake in Afya during the 4th quarter worth about $462,000. Daiwa Securities Group Inc. bought a new stake in Afya during the 4th quarter worth about $43,000. Finally, Squarepoint Ops LLC acquired a new position in Afya during the 3rd quarter valued at about $191,000. Institutional investors own 88.02% of the company’s stock.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Stories
- Five stocks we like better than Afya
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
